Received May 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| SMALLMNK | SMALLPOX + MONKEYPOX (JYNNEOS) | BAVARIAN NORDIC | 1 | FDP00015 | IM / LA |
The treatment was the first of a two-series vaccination; the outcome was uneventful, with no symptoms or signs of reaction reported.
None reported
On pre-exposure prophylaxis for HIV Screen for STD (sexually transmitted disease) Bipolar 2 disorder Environmental and seasonal allergies Need for hepatitis B vaccination Encounter for HIV pre-exposure prophylaxis Migraines Extrinsic asthma Sexual behavior with a high risk of exposure to communicable disease Patient in a clinical research study
cetirizine (ZYRTEC) 10 mg tab rimegepant 75 mg ODT tab emtricitabine-tenofovir alafenamide fumarate (DESCOVY) 200-25 mg tablet ARIPiprazole (ABILIFY) 10 mg tab traZODone (DESYREL) 50 mg tablet benztropine (COGENTIN) 0.5 mg tab albuterol HFA
NKDA
N/A